SurgePays, Inc.
SURG
$1.37
$0.097.03%
| Weiss Ratings | SURG - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E+ | |||
| Rating Factors | SURG - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Very Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | SURG - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.91 | |||
| Price History | SURG - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 6.20% | |||
| 30-Day Total Return | -12.74% | |||
| 60-Day Total Return | -25.14% | |||
| 90-Day Total Return | -20.81% | |||
| Year to Date Total Return | -23.03% | |||
| 1-Year Total Return | -79.61% | |||
| 2-Year Total Return | -70.97% | |||
| 3-Year Total Return | -54.03% | |||
| 5-Year Total Return | -90.04% | |||
| 52-Week High % Change | -82.50% | |||
| 52-Week Low % Change | 22.07% | |||
| Price | SURG - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $7.32 | |||
| 52-Week Low Price | $1.05 | |||
| 52-Week Low Price (Date) | Mar 04, 2025 | |||
| 52-Week High Price (Date) | Mar 07, 2024 | |||
| Valuation | SURG - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 25.45M | |||
| Enterprise Value | 6.33M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -1.13 | |||
| Earnings Per Share Growth | -178.29% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.30 | |||
| Price/Book (Q) | 0.76 | |||
| Enterprise Value/Revenue (TTM) | 0.08 | |||
| Price | $1.37 | |||
| Enterprise Value/EBITDA (TTM) | -0.29 | |||
| Enterprise Value/EBIT | -0.28 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | SURG - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 19.69M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | SURG - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 901 302 9587 | |||
| Address | 3124 Brother Boulevard Bartlett, TN 38133 | |||
| Website | surgepays.com | |||
| Country | United States | |||
| Year Founded | -- | |||
| Profitability | SURG - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -26.95% | |||
| Profit Margin | -27.38% | |||
| Management Effectiveness | SURG - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -33.25% | |||
| Return on Equity | -- | |||
| Income Statement | SURG - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 83.60M | |||
| Total Revenue (TTM) | 83.60M | |||
| Revenue Per Share | $4.25 | |||
| Gross Profit (TTM) | 4.35M | |||
| EBITDA (TTM) | -21.61M | |||
| EBIT (TTM) | -22.54M | |||
| Net Income (TTM) | -22.90M | |||
| Net Income Avl. to Common (TTM) | -22.90M | |||
| Total Revenue Growth (Q YOY) | -86.04% | |||
| Earnings Growth (Q YOY) | -303.61% | |||
| EPS Diluted (TTM) | -1.13 | |||
| EPS Diluted Growth (Q YOY) | -248.98% | |||
| Balance Sheet | SURG - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 23.72M | |||
| Cash Per Share (Q) | $1.20 | |||
| Total Current Assets (Q) | 33.91M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 33.28M | |||
| Current Ratio (Q) | 6.240 | |||
| Book Value Per Share (Q) | $1.69 | |||
| Total Assets (Q) | 41.50M | |||
| Total Current Liabilities (Q) | 5.43M | |||
| Total Debt (Q) | 4.49M | |||
| Total Liabilities (Q) | 8.22M | |||
| Total Common Equity (Q) | 33.16M | |||
| Cash Flow | SURG - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -10.59M | |||
| Cash from Financing (TTM) | 22.96M | |||
| Net Change in Cash (TTM) | 920.10K | |||
| Levered Free Cash Flow (TTM) | -6.05M | |||
| Cash from Operations (TTM) | -11.46M | |||
